1434-4726 < 1434-9949 < 1435-1250

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by 1434-9949

Number of relevant bibliographic references: 117.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000057 (2020)	Lili Pan [République populaire de Chine] ; Juan Du [République populaire de Chine] ; Jiayi Liu [République populaire de Chine] ; Hua Liao [République populaire de Chine] ; Xiaoli Liu [République populaire de Chine] ; Xi Guo [République populaire de Chine] ; Jing Liang [République populaire de Chine] ; Hongya Han [République populaire de Chine] ; Lixia Yang [République populaire de Chine] ; Yujie Zhou [République populaire de Chine]	Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
000081 (2020)	Francisco Vílchez-Oya [Espagne] ; Julia María Sánchez-Schmidt [Espagne] ; Anna Agustí [Espagne] ; Ana Pros [Espagne]	The use of tocilizumab in the treatment of refractory eosinophilic fasciitis: a case-based review.
000166 (2020)	Elyes Bouajina [Tunisie] ; Leith Zakraoui [Tunisie] ; Montassar Kchir [Tunisie] ; Samir Kochbati [Tunisie] ; Sofiene Baklouti [Tunisie]	Safety and efficacy of tocilizumab as monotherapy or in combination with methotrexate in Tunisian patients with active rheumatoid arthritis and inadequate response to disease-modifying anti-rheumatic drugs in conditions close to clinical practice.
000178 (2020)	Adelaide Sofia Batalha Figueiredo [Portugal] ; Ana Luísa Oliveira [Portugal] ; Ant Nio Caetano [Portugal] ; Maria Francisca Moraes-Fontes [Portugal]	SAPHO: has the time come for tailored therapy?
000187 (2020)	Durga Prasanna Misra [Inde] ; Vikas Agarwal [Inde] ; Armen Yuri Gasparyan ; Olena Zimba [Ukraine]	Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets
000390 (2020)	Patricia Richi [Espagne] ; Oriol Alonso [Espagne] ; María Dolores Martín [Espagne] ; Laura González-Hombrado [Espagne] ; Teresa Navío [Espagne] ; Marina Salido [Espagne] ; Jesús Llorente [Espagne] ; Cristina Andreu-Vázquez [Espagne] ; Cristina García-Fernández [Espagne] ; Ana Jiménez-Diaz [Espagne] ; Leticia Lojo [Espagne] ; Laura Cebrián [Espagne] ; Israel Thuissard-Vasallo [Espagne] ; María José Martínez De Aramayona [Espagne] ; Tatiana Cobo [Espagne] ; Marta García-Castro [Espagne] ; Patricia Castro [Espagne] ; M Nica Fernández-Castro [Espagne] ; Scar Illera [Espagne] ; Martina Steiner [Espagne] ; Santiago Mu Oz-Fernández [Espagne]	Evaluation of the immune response to hepatitis B vaccine in patients on biological therapy: results of the RIER cohort study.
000432 (2020)	Kosuke Ebina [Japon] ; Toru Hirano [Japon] ; Yuichi Maeda [Japon] ; Wataru Yamamoto [Japon] ; Motomu Hashimoto [Japon] ; Koichi Murata [Japon] ; Tohru Takeuchi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Akira Onishi [Japon] ; Sadao Jinno [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Keiichi Yamamoto [Japon] ; Atsushi Kumanogoh [Japon] ; Makoto Hirao [Japon]	Drug retention of secondary biologics or JAK inhibitors after tocilizumab or abatacept failure as first biologics in patients with rheumatoid arthritis -the ANSWER cohort study.
000831 (2019)	Laura Bazzichi [Italie] ; Francesca Nacci [Italie] ; Luigi Sinigaglia [Italie] ; Laura Bianchino [Italie] ; Roberto Caporali [Italie]	Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial.
000B13 (2019)	Vivian P. Bykerk [États-Unis] ; Andrew J K. Östör [Australie] ; José Alvaro-Gracia [Espagne] ; Karel Pavelka [République tchèque] ; José Andrés Román Ivorra [Espagne] ; Michael T. Nurmohamed [Pays-Bas] ; Yves Luder [Suisse] ; Paris N M. Sidiropoulos [États-Unis] ; Jenny Devenport [États-Unis] ; Jean Sibilia [France]	Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
000B14 (2019)	Francisco Airton Castro Rocha [Brésil] ; Joaquim Ivo Vasques Dantas Landim [Brésil] ; Mariana Lima Nour [Brésil] ; Valdenir Freire Peixoto Filho [Brésil] ; Leila Nascimento Da Rocha [Brésil] ; Marco Felipe Castro Da Silva [Brésil] ; Hermano Alexandre Lima Rocha [Brésil]	Long-term breastfeeding influences disease activity in a low-income juvenile idiopathic arthritis cohort.
000B34 (2019)	Sibel Balci [Turquie] ; Rabia Miray Kisla Ekinci [Turquie] ; Aysun Karabay Bayazit [Turquie] ; Engin Melek [Turquie] ; Dilek Dogruel [Turquie] ; Derya Ufuk Altintas [Turquie] ; Mustafa Yilmaz [Turquie]	Juvenile systemic lupus erythematosus: a single-center experience from southern Turkey.
000D17 (2019)	Samah Hamdy Elmedany [Égypte] ; Aly Elsayed Mohamed [Égypte] ; Sahar Mahfouz Abdel Galil [Égypte]	Efficacy and safety profile of intravenous tocilizumab versus intravenous abatacept in treating female Saudi Arabian patients with active moderate-to-severe rheumatoid arthritis.
001121 (2018)	Ciro Romano [Italie] ; Andrea Del Mastro [Italie] ; Ausilia Sellitto [Italie] ; Eleonora Solaro [Italie] ; Sergio Esposito [Italie] ; Giovanna Cuomo [Italie]	Tocilizumab reduces complement C3 and C4 serum levels in rheumatoid arthritis patients.
001136 (2018)	Mathilde Leclercq [France] ; M. Le Besnerais [France] ; V. Langlois [France] ; N. Girszyn [France] ; Y. Benhamou [France] ; C. Ngo [France] ; H. Levesque [France] ; M. Muraine [France] ; J. Gueudry [France]	Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review.
001216 (2018)	Sen Wang [République populaire de Chine] ; Qian He [République populaire de Chine] ; Zongwen Shuai [République populaire de Chine]	Risk of serious infections in biological treatment of patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysis.
001235 (2018)	F. Iannone [Italie] ; G. Ferraccioli [Italie] ; L. Sinigaglia [Italie] ; E G Favalli [Italie] ; P. Sarzi-Puttini [Italie] ; F. Atzeni [Italie] ; R. Gorla [Italie] ; C. Bazzani [Italie] ; M. Govoni [Italie] ; I. Farina [Italie] ; E. Gremese [Italie] ; A. Carletto [Italie] ; A. Giollo [Italie] ; M. Galeazzi [Italie] ; R. Foti [Italie] ; L. Bianchino [Italie] ; L. La Grasta [Italie] ; G. Lapadula [Italie]	Real-world experience of tocilizumab in rheumatoid arthritis: sub-analysis of data from the Italian biologics' register GISEA.
001299 (2018)	Violetta Opoka-Winiarska [Pologne] ; Zbigniew Uber [Pologne] ; Ekaterina Alexeeva [Russie] ; Vyacheslav Chasnyk [Russie] ; Irina Nikishina [Russie] ; Gra Yna D Bowska [Pologne] ; El Bieta Smolewska [Pologne]	Long-term, interventional, open-label extension study evaluating the safety of tocilizumab treatment in patients with polyarticular-course juvenile idiopathic arthritis from Poland and Russia who completed the global, international CHERISH trial.
001338 (2018)	Zs Fia Kardos [Hongrie] ; Csaba Oláh [Hongrie] ; Mariann Sepsi [Hongrie] ; Attila Sas [Hongrie] ; Lászl Kostyál [Hongrie] ; Tünde B Ta [Hongrie] ; Harjit Pal Bhattoa [Hongrie] ; Katalin Hodosi [Hongrie] ; György Kerekes [Hongrie] ; Lászl Tamási [Hongrie] ; Dániel Bereczki [Hongrie] ; Zoltán Szekanecz [Hongrie]	Increased frequency of temporal acoustic window failure in rheumatoid arthritis: a manifestation of altered bone metabolism?
001441 (2018)	Sang-Cheol Bae [Corée du Sud] ; Young Ho Lee [Corée du Sud]	Comparison of the efficacy and tolerability of tocilizumab, sarilumab, and sirukumab in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
001561 (2017)	Mari Kihara [Royaume-Uni] ; Rebecca Davies [Royaume-Uni] ; Lianne Kearsley-Fleet [Royaume-Uni] ; Kath D. Watson [Royaume-Uni] ; Mark Lunt [Royaume-Uni] ; Deborah P M. Symmons [Royaume-Uni] ; Kimme L. Hyrich [Royaume-Uni]	Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis.
001598 (2017)	Michael Henrickson [États-Unis] ; Heng Wang [États-Unis]	Tocilizumab reverses cerebral vasculopathy in a patient with homozygous SAMHD1 mutation.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i -k "1434-9949" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/ISSN.i  \
                -Sk "1434-9949" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    ISSN.i
   |clé=    1434-9949
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021